Early myocardial ischemia and hypoxia trigger compensatory mechanisms, but prolonged hypoxic damage increases pro-inflammatory cytokines (IL-1, IL-6, and TNF-) and reactive species (O2, OH, and H2O2), and shifts metabolism from fatty acid oxidation to glycolysis, further worsening cardiac hypertrophy, myocarditis, and heart failure (Zuo et al., 2024)
Patients who use the tirzepatide treatment period to establish sustainable lifestyle habits may retain some autoimmune benefit even after stopping the drug, though metabolic-related improvements may diminish
Keep the Saxenda pen and packaging available for reference, as healthcare professionals may need to confirm the medication details
And that difference matters